IL212850A0 - Novel method for the preparation of granulates of active constituents, and granulates as obtained - Google Patents

Novel method for the preparation of granulates of active constituents, and granulates as obtained

Info

Publication number
IL212850A0
IL212850A0 IL212850A IL21285011A IL212850A0 IL 212850 A0 IL212850 A0 IL 212850A0 IL 212850 A IL212850 A IL 212850A IL 21285011 A IL21285011 A IL 21285011A IL 212850 A0 IL212850 A0 IL 212850A0
Authority
IL
Israel
Prior art keywords
granulates
preparation
novel method
active constituents
constituents
Prior art date
Application number
IL212850A
Other languages
English (en)
Original Assignee
Debregeas Et Associes Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40348849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL212850(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Debregeas Et Associes Pharma filed Critical Debregeas Et Associes Pharma
Publication of IL212850A0 publication Critical patent/IL212850A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fertilizers (AREA)
  • Glanulating (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL212850A 2008-11-14 2011-05-12 Novel method for the preparation of granulates of active constituents, and granulates as obtained IL212850A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0857764A FR2938432B1 (fr) 2008-11-14 2008-11-14 Nouveau procede de preparation de granules de principes actifs, et granules tels qu'obtenus
PCT/FR2009/052180 WO2010055268A1 (fr) 2008-11-14 2009-11-13 Nouveau procédé de préparation de granulés de principes actifs, et granulés tels qu'obtenus

Publications (1)

Publication Number Publication Date
IL212850A0 true IL212850A0 (en) 2011-07-31

Family

ID=40348849

Family Applications (1)

Application Number Title Priority Date Filing Date
IL212850A IL212850A0 (en) 2008-11-14 2011-05-12 Novel method for the preparation of granulates of active constituents, and granulates as obtained

Country Status (25)

Country Link
US (1) US20110280945A1 (enExample)
EP (1) EP2349226A1 (enExample)
JP (1) JP5608681B2 (enExample)
KR (1) KR101585705B1 (enExample)
CN (1) CN102223879A (enExample)
AR (1) AR074330A1 (enExample)
AU (1) AU2009315449B2 (enExample)
BR (1) BRPI0916019A2 (enExample)
CA (1) CA2743753A1 (enExample)
CL (1) CL2011001115A1 (enExample)
CO (1) CO6382108A2 (enExample)
CU (1) CU20110107A7 (enExample)
EA (1) EA201100757A1 (enExample)
FR (1) FR2938432B1 (enExample)
IL (1) IL212850A0 (enExample)
MA (1) MA32789B1 (enExample)
MX (1) MX2011005072A (enExample)
NZ (1) NZ592857A (enExample)
PE (1) PE20110945A1 (enExample)
SG (1) SG195651A1 (enExample)
TN (1) TN2011000235A1 (enExample)
TW (1) TWI522113B (enExample)
UA (1) UA103781C2 (enExample)
WO (1) WO2010055268A1 (enExample)
ZA (1) ZA201103543B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2971422B1 (fr) * 2011-02-11 2016-05-20 Debregeas Et Associes Pharma Granules d'acide gamma-hydroxybutyrique
US20140127296A1 (en) * 2012-11-05 2014-05-08 Kenneth John Tibbs Pharmaceutical preparation and method for treatment of diabetes
US9241956B2 (en) * 2012-11-05 2016-01-26 Kenneth John Tibbs Pharmaceutical preparation and method for treatment of diabetes
US11058635B1 (en) * 2020-10-15 2021-07-13 King Abdulaziz University Oral administration of 5-FU in a gelling nanosuspension for targeted delivery to treat colorectal cancers
KR20240157168A (ko) * 2023-04-24 2024-11-01 주식회사 케이티앤지 바인더를 사용하는 파우치 충진 물질의 제조 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
JPH08310969A (ja) * 1995-05-22 1996-11-26 Lion Corp 固形薬品組成物及びその製造方法
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
PT1178778E (pt) * 1999-05-17 2006-06-30 D B F Granulos que contem uma substancia vegetal e o seu procedimento de preparacao
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US9247765B2 (en) * 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
FR2880541B1 (fr) * 2005-01-10 2008-02-22 Amalric Veret Une nouvelle formule de plantes sous forme de micro-granules de xilitol pour renforcer les effets des plantes et leurs proprietes par une meilleure assimilation
US20060182796A1 (en) * 2005-02-03 2006-08-17 Abrika Pharmaceuticals, Inc. Taste masked pharmaceutical compositions
KR101468053B1 (ko) * 2006-08-31 2014-12-02 앱탈리스 파마테크, 인코포레이티드 약 염기성 약물의 고용체를 포함하는 약물 전달 시스템
EP2110413B1 (en) * 2007-02-14 2013-03-20 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Dispersing agent for organic pigment and use thereof
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system

Also Published As

Publication number Publication date
CO6382108A2 (es) 2012-02-15
CU20110107A7 (es) 2012-01-31
EA201100757A1 (ru) 2011-12-30
NZ592857A (en) 2013-07-26
CN102223879A (zh) 2011-10-19
ZA201103543B (en) 2012-01-25
BRPI0916019A2 (pt) 2015-11-10
CL2011001115A1 (es) 2011-11-11
CA2743753A1 (fr) 2010-05-20
TWI522113B (zh) 2016-02-21
AU2009315449B2 (en) 2015-03-26
UA103781C2 (uk) 2013-11-25
EP2349226A1 (fr) 2011-08-03
FR2938432B1 (fr) 2011-05-20
SG195651A1 (en) 2013-12-30
JP2012508786A (ja) 2012-04-12
AR074330A1 (es) 2011-01-05
MA32789B1 (fr) 2011-11-01
US20110280945A1 (en) 2011-11-17
TW201029667A (en) 2010-08-16
PE20110945A1 (es) 2012-02-01
JP5608681B2 (ja) 2014-10-15
AU2009315449A1 (en) 2010-05-20
KR101585705B1 (ko) 2016-01-15
WO2010055268A1 (fr) 2010-05-20
MX2011005072A (es) 2011-10-03
TN2011000235A1 (fr) 2012-12-17
KR20110095888A (ko) 2011-08-25
FR2938432A1 (fr) 2010-05-21

Similar Documents

Publication Publication Date Title
HRP20190408T1 (hr) Ariloazol-2-il-cijanoetilamino-spojevi, postupak njihove proizvodnje i postupak njihove uporabe
IL211541A0 (en) Co-crystal compositions, methods of producing the same and uses thereof
PT2379730E (pt) Método para a preparação de dióis
IL209188A (en) Sweetener, preparations containing it and methods of manufacture
EP2282735A4 (en) COMPOUNDS, COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
SI2151428T1 (sl) Postopek za pripravo agomelatina
EP2340297A4 (en) COMPOSITION, ITS MANUFACTURING METHOD AND USE
AU2009254929A8 (en) An improved process for the preparation of amines
WO2010065586A3 (en) Preparation of capecitabine
IL215980A (en) An intermediate substance of Artemnam, a preparation containing it and methods for its preparation
EG26332A (en) Process for the preparation of benzonoprons
IL212850A0 (en) Novel method for the preparation of granulates of active constituents, and granulates as obtained
GB0800570D0 (en) Composition, process for preparation and method of use
PT2151429E (pt) Novo processo de síntese da agomelatina
ZA201101520B (en) Phenanthrenone compounds,compositions and methods
PL2896614T3 (pl) Sposoby i związki do wytwarzania normorfinanów
EP2173695A4 (en) PROCESS FOR THE PREPARATION OF CIS-4-TERT.-BUTYLCYCLOHEXANOL
IL211382A0 (en) Process for the preparation of ethanedinitrile
PL386388A1 (pl) Sposób otrzymywania 2, 3-epoksybutan-1-olu
PL386389A1 (pl) Sposób otrzymywania 2, 3-epoksybutan-1-olu
PL386077A1 (pl) Sposób oznaczania krzewistości traw
GB0812613D0 (en) Process for the preparation of 1-deoxyidonojirimycin
EP2289989A4 (en) ADDITIVE, MANUFACTURING METHOD THEREOF, AND COMPOSITION CONTAINING SAME